DE69939694D1 - 'patched-2' protein aus wirbeltieren - Google Patents
'patched-2' protein aus wirbeltierenInfo
- Publication number
- DE69939694D1 DE69939694D1 DE69939694T DE69939694T DE69939694D1 DE 69939694 D1 DE69939694 D1 DE 69939694D1 DE 69939694 T DE69939694 T DE 69939694T DE 69939694 T DE69939694 T DE 69939694T DE 69939694 D1 DE69939694 D1 DE 69939694D1
- Authority
- DE
- Germany
- Prior art keywords
- patched
- swivel
- protein out
- immunoadhesins
- ests
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Addiction (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/060,939 US6709838B1 (en) | 1998-04-15 | 1998-04-15 | Nucleic acid encoding patched-2 |
| PCT/US1999/007417 WO1999053058A1 (en) | 1998-04-15 | 1999-04-02 | Vertebrate patched-2 protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69939694D1 true DE69939694D1 (de) | 2008-11-20 |
Family
ID=22032676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69939694T Expired - Lifetime DE69939694D1 (de) | 1998-04-15 | 1999-04-02 | 'patched-2' protein aus wirbeltieren |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6709838B1 (https=) |
| EP (1) | EP1071779B1 (https=) |
| JP (2) | JP4693237B2 (https=) |
| AT (1) | ATE410513T1 (https=) |
| AU (1) | AU765918B2 (https=) |
| CA (1) | CA2323572C (https=) |
| CY (1) | CY1108619T1 (https=) |
| DE (1) | DE69939694D1 (https=) |
| DK (1) | DK1071779T3 (https=) |
| ES (1) | ES2316192T3 (https=) |
| IL (3) | IL138585A0 (https=) |
| PT (1) | PT1071779E (https=) |
| WO (1) | WO1999053058A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1037982A1 (en) * | 1997-12-08 | 2000-09-27 | Ontogeny, Inc. | Human patched genes and proteins, and uses related thereto |
| SE9803393D0 (sv) * | 1998-10-06 | 1998-10-06 | Karolinska Innovations Ab | A novel component in the hedgehog signalling pathway |
| GB9908798D0 (en) * | 1999-04-16 | 1999-06-09 | Pharmacia & Upjohn Spa | Human homologues of fused gene |
| WO2001041786A1 (en) * | 1999-12-10 | 2001-06-14 | The General Hospital Corporation | METHODS TO STIMULATE INSULIN PRODUCTION BY PANCREATIC β-CELLS |
| SE0000345D0 (sv) * | 2000-02-03 | 2000-02-03 | Karolinska Innovations Ab | New matter |
| EP1229046A3 (en) * | 2001-01-30 | 2004-02-25 | Aeomica, Inc. | Human testis expressed patched like protein |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| WO1995018856A1 (en) | 1993-12-30 | 1995-07-13 | President And Fellows Of Harvard College | Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| US6027882A (en) | 1994-10-07 | 2000-02-22 | The Regents Of The University Of California | Patched genes and their use for diagnostics |
| AU4001195A (en) | 1994-10-07 | 1996-05-02 | Board Of Trustees Of The Leland Stanford Junior University | Patched genes and their use |
| EP0879888A3 (en) | 1997-05-23 | 1999-07-14 | Smithkline Beecham Plc | Patched-2 polypeptides and polynucleotides and methods for their production |
| EP1037982A1 (en) | 1997-12-08 | 2000-09-27 | Ontogeny, Inc. | Human patched genes and proteins, and uses related thereto |
| US6022708A (en) | 1998-02-26 | 2000-02-08 | Genentech, Inc. | Fused |
| SE9803393D0 (sv) * | 1998-10-06 | 1998-10-06 | Karolinska Innovations Ab | A novel component in the hedgehog signalling pathway |
-
1998
- 1998-04-15 US US09/060,939 patent/US6709838B1/en not_active Expired - Lifetime
-
1999
- 1999-04-02 DE DE69939694T patent/DE69939694D1/de not_active Expired - Lifetime
- 1999-04-02 CA CA2323572A patent/CA2323572C/en not_active Expired - Lifetime
- 1999-04-02 AT AT99945688T patent/ATE410513T1/de active
- 1999-04-02 WO PCT/US1999/007417 patent/WO1999053058A1/en not_active Ceased
- 1999-04-02 PT PT99945688T patent/PT1071779E/pt unknown
- 1999-04-02 EP EP99945688A patent/EP1071779B1/en not_active Expired - Lifetime
- 1999-04-02 JP JP2000543606A patent/JP4693237B2/ja not_active Expired - Lifetime
- 1999-04-02 IL IL13858599A patent/IL138585A0/xx unknown
- 1999-04-02 AU AU52657/99A patent/AU765918B2/en not_active Expired
- 1999-04-02 DK DK99945688T patent/DK1071779T3/da active
- 1999-04-02 ES ES99945688T patent/ES2316192T3/es not_active Expired - Lifetime
-
2000
- 2000-09-20 IL IL138585A patent/IL138585A/en not_active IP Right Cessation
-
2008
- 2008-12-03 CY CY20081101409T patent/CY1108619T1/el unknown
-
2009
- 2009-10-19 JP JP2009240086A patent/JP2010046077A/ja not_active Withdrawn
-
2010
- 2010-05-16 IL IL205793A patent/IL205793A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL205793A (en) | 2015-01-29 |
| ATE410513T1 (de) | 2008-10-15 |
| WO1999053058A1 (en) | 1999-10-21 |
| AU5265799A (en) | 1999-11-01 |
| CA2323572C (en) | 2011-10-18 |
| DK1071779T3 (da) | 2009-02-16 |
| IL138585A0 (en) | 2001-10-31 |
| CA2323572A1 (en) | 1999-10-21 |
| US6709838B1 (en) | 2004-03-23 |
| JP4693237B2 (ja) | 2011-06-01 |
| EP1071779B1 (en) | 2008-10-08 |
| AU765918B2 (en) | 2003-10-02 |
| JP2002511263A (ja) | 2002-04-16 |
| PT1071779E (pt) | 2009-01-13 |
| EP1071779A1 (en) | 2001-01-31 |
| JP2010046077A (ja) | 2010-03-04 |
| IL138585A (en) | 2010-11-30 |
| CY1108619T1 (el) | 2014-04-09 |
| ES2316192T3 (es) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137743A0 (en) | Human homolog of the drosophilia protein "fused" | |
| EP1009814A4 (en) | KDR, A HUMAN TYROSIN KINASE RECEPTOR | |
| BR9206578A (pt) | Seqüência de DNA sintético tendo melhorada atividade inseticida em milho. | |
| CA2174529A1 (en) | Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof | |
| WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
| DE69833784D1 (de) | Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren | |
| WO1996015144A3 (en) | Chromosome 21 gene marker, compositions and methods using same | |
| DE69737978D1 (de) | Als 2f1 bezeichnetes rezeptorprotein | |
| CY1108619T1 (el) | Πρωτεϊνη σπονδυλωτων patched-2 | |
| DK1064376T3 (da) | GFR-alpha3 og dets anvendelser | |
| ATE450603T1 (de) | Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren | |
| BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
| WO1999027098A3 (en) | A-33 related antigens and their pharmacological uses | |
| EP1117779A4 (en) | -i (MORAXELLA CATARRHALIS) PrPTEIN; NUCLEAR SAUCE SEQUENCE AND APPLICATIONS | |
| EP0816504A3 (en) | Platelet activating factor acetylhdrolase, and gene thereof | |
| DE69734596D1 (de) | "smoothened" proteine aus wirbeltieren | |
| PT773999E (pt) | Receptor orfao or-1 pertencente a familia de receptores nucleares | |
| WO1997008317A3 (en) | Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof | |
| WO2000040607A3 (en) | Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor | |
| WO2000065025A3 (en) | Dna molecules encoding human endothelin converting enzyme 3 | |
| MXPA01011563A (es) | Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados. | |
| AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same | |
| WO2001057086A3 (en) | Novel human g protein coupled receptor proteins and polynucleotides encoding the same | |
| WO2003099995A3 (en) | Murine ortholog of the human disrupted-in-schizophrenia 1 gene | |
| ATE492640T1 (de) | Loslösendes protein 5 - ucp5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |